Traders should monitor the March 5 call for details on synergies, revenue potential from expanded AI offerings, and management's outlook for the DeepHealth segment. The integration of Gleamer could accelerate RadNet's transition into high-margin digital health services.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 4 $71.33entry
- T+1 · 9mo ago −6.53%α −5.96% · $66.67
- T+5 · 8mo ago −14.20%α −12.87% · $61.20
- T+20 · 8mo ago −22.46%α −18.04% · $55.31
- T+60 · 6mo ago −22.46%α −32.55% · $55.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
RadNet, Inc. is hosting an investor call to discuss its recently completed acquisition of Gleamer SAS, a France-based AI medical imaging company, and its broader Digital Health strategy under the DeepHealth brand. The acquisition enhances RadNet's AI-powered diagnostic capabilities across imaging modalities, including X-ray, mammography, CT, and MRI, with Gleamer having analyzed over 30 million exams globally.
Key Facts
- RadNet completed the acquisition of Gleamer SAS, an AI medical imaging company founded in 2017.
- Gleamer’s AI solutions support radiologists in diagnosing across X-ray, mammography, CT, and MRI.
- Gleamer has analyzed over 30 million exams across 2,250 locations in 44 countries.
- 60 peer-reviewed publications validate the performance of Gleamer’s AI tools.
- Investor call on March 5, 2026, will detail the integration and RadNet’s Digital Health strategy under DeepHealth.
Financial Impact
Strategic enhancement of RadNet's AI capabilities; specific deal value not disclosed but likely material given Gleamer's global footprint and technology portfolio.
Risk Factors
- Integration risk in combining Gleamer’s technology and operations into RadNet’s existing platform.
- Regulatory or reimbursement challenges for AI-driven diagnostic tools in key markets.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249150 |
Track record
21 reports on RDNT
1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +26.65% at T+60 after the Jun 25, 2026 report. 1 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $76.04 Now $76.89 +1.12% settles Feb 10
- Nov 9, 20267d ago 8-K Bullish 6/10 No price data
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $78.38 Now $76.89 −1.90% settles Feb 5
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $73.54 Now $76.89 +4.56% settles Jan 26
- Oct 26, 202621d ago 8-K Neutral 6/10 Entry $73.54 Now $76.89 +4.56% settles Jan 25
- Oct 26, 202621d ago Press Release Bullish 6/10 Entry $73.54 Now $76.89 +4.56% settles Jan 25
- Oct 1, 20266w ago Press Release Neutral 2/10 Entry $67.70 Now $76.89 +13.57% settles Dec 28
- Aug 10, 202614w ago 8-K Bullish 6/10 No price data
- Aug 9, 202614w ago Press Release Mixed 6/10 Entry $77.28 to $73.18 Now $76.89 −0.50% ▼ −5.31% −2.89% vs SPY
- Jun 25, 202620w ago Press Release Bullish 5/10 Entry $60.01 to $76.00 Now $76.89 +28.13% ▲ +26.65% +22.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers